Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.
This report aims to provide a comprehensive presentation of the global market for Anti-thrombin III Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-thrombin III Testing. This report contains market size and forecasts of Anti-thrombin III Testing in global, including the following market information:
Global Anti-thrombin III Testing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-antithrombin-iii-testing-forecast-2023-2030-536
?-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites. A single glycosylation site remains consistently un-occupied in the minor form of antithrombin, ?-antithrombin.
Antithrombin activity is increased by anticoagulant heparin, which enhances the binding of antithrombin to factor II and factor X.
Antithrombin is a serpin (serine protease inhibitor) similar in structure to other plasma protease inhibitors like alpha 1-antichymotrypsin, alpha 2-antiplasmin and Heparin cofactor II.
We surveyed the Anti-thrombin III Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-thrombin III Testing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Anti-thrombin III Testing Market Segment Percentages, by Type, 2022 (%)
Diagnosis of antithrombin deficiency
Activity assays
Immunological assays
Global Anti-thrombin III Testing Market Segment Percentages, by Application, 2022 (%)
Hospital
Research institute
Clinic
Other
Global Anti-thrombin III Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Anti-thrombin III Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-thrombin III Testing revenues share in global market, 2022 (%)
Abbott Laboratories
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Chapter 1: Introduces the definition of Anti-thrombin III Testing, market overview.
Chapter 2: Global Anti-thrombin III Testing market size in revenue.
Chapter 3: Detailed analysis of Anti-thrombin III Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-thrombin III Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-antithrombin-iii-testing-forecast-2023-2030-536
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Comments